个性化医疗的最新概述:下一代范式

Q3 Pharmacology, Toxicology and Pharmaceutics International Journal of Pharmaceutical Quality Assurance Pub Date : 2023-06-25 DOI:10.25258/ijpqa.14.2.34
Himanshu Sharma, Urmi Bhadouria, Teenu Sharma, Arindam Chatterjee, Parveen Kumar
{"title":"个性化医疗的最新概述:下一代范式","authors":"Himanshu Sharma, Urmi Bhadouria, Teenu Sharma, Arindam Chatterjee, Parveen Kumar","doi":"10.25258/ijpqa.14.2.34","DOIUrl":null,"url":null,"abstract":"Personalized medicine is a translational approach that utilizes an individual’s genetic profile to guide illness prevention, diagnosis, and treatment choices. The human genome project data is being used to enhance personalized treatment. “Personalised” medicine is beneficial over “individualized” medicine as it suggests that future hazards may be predicted based on the individual’s genes. The advancement of technology for personalized medicine depends heavily on standardization, integration, and harmonization. The scientific practices at various research sites, the connection between science and healthcare, and the relationship between science, healthcare, and broader society, including the legal and ethical paradigms, the dominant cultural and political ethos, and the expectations of patients and citizens - all need to be in harmony. There are several descriptions of the current existing legislation that regulates genetic screening and genomic medical services in various countries around the world, highlighting discrepancies and specifying areas of law where harmonization may be needed to enable the use of individually tailored medication globally. The promise of personalized medicine can only be fulfilled by placing the individual at the centre of personalized medicine and tailoring care to each patient’s unique psychological and social needs in addition to their biological profiles.","PeriodicalId":14260,"journal":{"name":"International Journal of Pharmaceutical Quality Assurance","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An Updated Overview on Personalized Medicine: The Next-Gen Paradigm\",\"authors\":\"Himanshu Sharma, Urmi Bhadouria, Teenu Sharma, Arindam Chatterjee, Parveen Kumar\",\"doi\":\"10.25258/ijpqa.14.2.34\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Personalized medicine is a translational approach that utilizes an individual’s genetic profile to guide illness prevention, diagnosis, and treatment choices. The human genome project data is being used to enhance personalized treatment. “Personalised” medicine is beneficial over “individualized” medicine as it suggests that future hazards may be predicted based on the individual’s genes. The advancement of technology for personalized medicine depends heavily on standardization, integration, and harmonization. The scientific practices at various research sites, the connection between science and healthcare, and the relationship between science, healthcare, and broader society, including the legal and ethical paradigms, the dominant cultural and political ethos, and the expectations of patients and citizens - all need to be in harmony. There are several descriptions of the current existing legislation that regulates genetic screening and genomic medical services in various countries around the world, highlighting discrepancies and specifying areas of law where harmonization may be needed to enable the use of individually tailored medication globally. The promise of personalized medicine can only be fulfilled by placing the individual at the centre of personalized medicine and tailoring care to each patient’s unique psychological and social needs in addition to their biological profiles.\",\"PeriodicalId\":14260,\"journal\":{\"name\":\"International Journal of Pharmaceutical Quality Assurance\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutical Quality Assurance\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25258/ijpqa.14.2.34\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical Quality Assurance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25258/ijpqa.14.2.34","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

个性化医学是一种转化方法,它利用个人的基因特征来指导疾病的预防、诊断和治疗选择。人类基因组计划的数据正被用于加强个性化治疗。“个体化”医疗比“个体化”医疗更有益,因为它表明,未来的危害可以根据个人的基因来预测。个性化医疗技术的进步在很大程度上取决于标准化、一体化和协调。各个研究地点的科学实践、科学与医疗保健之间的联系,以及科学、医疗保健和更广泛的社会之间的关系,包括法律和伦理范式、占主导地位的文化和政治思潮,以及患者和公民的期望,都需要和谐相处。对世界各国规范基因筛查和基因组医疗服务的现行立法进行了若干描述,强调了差异,并具体说明了可能需要进行协调的法律领域,以便在全球范围内使用量身定制的药物。个性化医疗的承诺只能通过将个人置于个性化医疗的中心,并根据每个患者独特的心理和社会需求以及他们的生物特征来定制护理来实现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An Updated Overview on Personalized Medicine: The Next-Gen Paradigm
Personalized medicine is a translational approach that utilizes an individual’s genetic profile to guide illness prevention, diagnosis, and treatment choices. The human genome project data is being used to enhance personalized treatment. “Personalised” medicine is beneficial over “individualized” medicine as it suggests that future hazards may be predicted based on the individual’s genes. The advancement of technology for personalized medicine depends heavily on standardization, integration, and harmonization. The scientific practices at various research sites, the connection between science and healthcare, and the relationship between science, healthcare, and broader society, including the legal and ethical paradigms, the dominant cultural and political ethos, and the expectations of patients and citizens - all need to be in harmony. There are several descriptions of the current existing legislation that regulates genetic screening and genomic medical services in various countries around the world, highlighting discrepancies and specifying areas of law where harmonization may be needed to enable the use of individually tailored medication globally. The promise of personalized medicine can only be fulfilled by placing the individual at the centre of personalized medicine and tailoring care to each patient’s unique psychological and social needs in addition to their biological profiles.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
International Journal of Pharmaceutical Quality Assurance
International Journal of Pharmaceutical Quality Assurance Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
CiteScore
0.80
自引率
0.00%
发文量
0
期刊介绍: INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE is a quarterly international journal publishing the finest peer-reviewed research in the field of Pharmaceutical Quality Assurance and Pharmaceutical Analysis on the basis of its originality, importance, disciplinary interest, timeliness, accessibility, elegance, and surprising conclusions. IJPQA also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.
期刊最新文献
UV Spectrophotometric Analysis of Apigenin in Topical Fungal Formulation containing Extract of Leonotis nepetaefolia (L) R. Br. Formulation and Development of Polyherbal Ointment containing Clerodendrum serratum, Solanum xanthocarpum, and Nyctanthes arbortristis Extracts and Assessment of Anti-inflammatory Activity in Carrageenan-Induced Paw Edema Model A Stability Indicating RP-HPLC Method for the Estimation of Nebivolol Hydrochloride in Human Plasma Formulation Development and Evaluation of Freeze-dried Aviptadil Injection using Mannitol as Cryoprotectant Supercritical CO2 Extraction, Quantification and Pharmacological Screening of Steroidal Saponins from Fruits of Momordica charantia L
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1